Symbiotic Capital Life Science Credit Fund, L.P. — Form D/A
Symbiotic Capital Life Science Credit Fund, L.P. of LOS ANGELES, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-05-23. $160.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-05-23
- Form: D/A
- Accession: 0001978089-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $160.2M
- Minimum investment: $10.0M
- Investors: 65
- Date of first sale: 2023-06-05
- Security types: equity, fund interests
- SEC file number: 021-482761
Issuer
- Name: Symbiotic Capital Life Science Credit Fund, L.P.
- CIK: 0001978089
- Entity type: Limited Partnership
- Jurisdiction: CALIFORNIA
- Incorporated: 2023
- Address: 10100 SANTA MONICA BLVD, FLOOR 15 10100 Santa Monica Blvd, Floor 15, LOS ANGELES, CA, 90067
- Phone: 424-313-1550
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Arie Belldegrun | Director | LOS ANGELES, CA |
| Himani Bhalla | Director | LOS ANGELES, CA |
| Joshua Bradley | Director | LOS ANGELES, CA |
| Russell Goldsmith | Director | LOS ANGELES, CA |
| - Symbiotic Capital Life Science Credit Fund GP, L.P. | Promoter | LOS ANGELES, CA |
| Russell Goldsmith | Related Person | LOS ANGELES, CA |
| Joshua Bradley | Related Person | LOS ANGELES, CA |
| Arie Belldegrun | Related Person | LOS ANGELES, CA |
| Himani Bhalla | Related Person | LOS ANGELES, CA |
Other filings by this issuer (3)
More